Vitrafy Life Sciences Limited
Research Vitrafy Life Sciences Limited (VFY.AX) on Bullrun: market cap AUD 218.05M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVFY.AX
- ExchangeAU
- CountryAustralia
- SectorTechnology
- IndustrySoftware - Infrastructure
- CurrencyAUD
- Market capAUD 218.05M
- Financial periodFY2026
- RevenueAUD 168.73K
- Revenue growth159.1%
- Net income-AUD 16.17M
- Free cash flow-AUD 16.31M
- Gross margin100.0%
Valuation Snapshot
latest market cap is AUD 218.05M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | AUD 168.73K | -AUD 16.17M | -AUD 16.31M | 100.0% | n/a | AUD 26.10M | AUD 302.57K | AUD 41.11M |
| FY2025 | AUD 65.11K | -AUD 32.71M | -AUD 8.80M | 100.0% | -0.73 | AUD 19.52M | AUD 392.36K | AUD 28.77M |
| FY2024 | AUD 37.00K | -AUD 10.43M | -AUD 6.80M | 100.0% | -0.16 | AUD 37.97M | AUD 475.00K | AUD 39.99M |
| FY2023 | AUD 32.00K | -AUD 7.81M | -AUD 5.05M | 100.0% | -0.12 | n/a | n/a | AUD 0 |
| FY2022 | n/a | n/a | n/a | n/a | -0.12 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 218.05M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Vitrafy Life Sciences Limited
Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. It offers cryopreservation medical devices, including freezers, thawers, and packaging solutions. The company also provides the LifeChain software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials, as well as the Guardion, non-medical hardware device.
Related stock research
Other Technology stocks
Frequently asked questions
What is Vitrafy Life Sciences Limited's market cap?
Vitrafy Life Sciences Limited's market capitalization is AUD 218.05M.
What does Vitrafy Life Sciences Limited do?
Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. It offers cryopreservation medical devices, including freezers, thawers, and packaging solutions. The company also provides the LifeChain software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials, as well as the Guardion, non-medical hardware device. Its cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs.